Drug Trials Snapshots: IMJUDO
Summary
IMJUDO is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated in combination with durvalumab, for the treatment of adult patients...
Description
IMJUDO is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated in combination with durvalumab, for the treatment of adult patients...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source